Cargando…

Inhalable Formulation Based on Lipid–Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast

[Image: see text] Here, novel lipid–polymer hybrid nanoparticles (LPHNPs), targeted to lung macrophages, were realized as potential carriers for Roflumilast administration in the management of chronic obstructive pulmonary disease (COPD). To achieve this, Roflumilast-loaded fluorescent polymeric nan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Craparo, Emanuela F., Cabibbo, Marta, Scialabba, Cinzia, Giammona, Gaetano, Cavallaro, Gennara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364311/ https://www.ncbi.nlm.nih.gov/pubmed/35899612 http://dx.doi.org/10.1021/acs.biomac.2c00576

Ejemplares similares

Rapamycin-Loaded Polymeric Nanoparticles as an Advanced Formulation for Macrophage Targeting in Atherosclerosis
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2021)

Development of New Targeted Inulin Complex Nanoaggregates for siRNA Delivery in Antitumor Therapy
por: Cavallaro, Gennara, et al.
Publicado: (2021)

Cholesterol-Inulin Conjugates for Efficient SN38 Nuclear Delivery: Nanomedicines for Precision Cancer Therapy
por: Mauro, Nicolò, et al.
Publicado: (2022)

Design of New Polyaspartamide Copolymers for siRNA Delivery in Antiasthmatic Therapy
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2020)

Combining Inulin Multifunctional Polycation and Magnetic Nanoparticles: Redox-Responsive siRNA-Loaded Systems for Magnetofection
por: Sardo, Carla, et al.
Publicado: (2019)

Margination of Fluorescent Polylactic Acid–Polyaspartamide based Nanoparticles in Microcapillaries In Vitro: the Effect of Hematocrit and Pressure
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2017)

Polyaspartamide-Based Nanoparticles Loaded with Fluticasone Propionate and the In Vitro Evaluation towards Cigarette Smoke Effects
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2017)

Polymer-Based Systems for Controlled Release and Targeting of Drugs
por: Giammona, Gaetano, et al.
Publicado: (2019)

Development of a novel rapamycin loaded nano- into micro-formulation for treatment of lung inflammation
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2022)

Sustained-Release Powders Based on Polymer Particles for Pulmonary Delivery of Beclomethasone Dipropionate in the Treatment of Lung Inflammation
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2023)

Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2
por: Bondì, Maria Luisa, et al.
Publicado: (2011)

Biomedical Applications of Polylactide (PLA) and Its Copolymers
por: Giammona, Gaetano, et al.
Publicado: (2018)

Effects in cigarette smoke stimulated bronchial epithelial cells of a corticosteroid entrapped into nanostructured lipid carriers
por: Bondì, Maria Luisa, et al.
Publicado: (2014)

mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2021)

Carbon Nanodots as Functional Excipient to Develop Highly Stable and Smart PLGA Nanoparticles Useful in Cancer Theranostics
por: Mauro, Nicolò, et al.
Publicado: (2020)

Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
por: Bondì, Maria Luisa, et al.
Publicado: (2014)

Bromelain Loaded Lipid-Polymer Hybrid Nanoparticles for Oral Delivery: Formulation and Characterization
por: Ebrahimian, Mahboubeh, et al.
Publicado: (2022)

Pressure-Dependent Tuning of Photoluminescence and Size Distribution of Carbon Nanodots for Theranostic Anticancer Applications
por: Mauro, Nicolò, et al.
Publicado: (2020)

Carbon Nanodots for On Demand Chemophotothermal Therapy Combination to Elicit Necroptosis: Overcoming Apoptosis Resistance in Breast Cancer Cell Lines
por: Nicosia, Aldo, et al.
Publicado: (2020)

Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization
por: Momin, Mohammad A. M., et al.
Publicado: (2021)

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
por: Di Gesù, Roberto, et al.
Publicado: (2018)

Lipid-Polymer Hybrid Nanocarriers for Oral Delivery of Felodipine: Formulation, Characterization and Ex Vivo Evaluation
por: Drais, Hayder Kadhim, et al.
Publicado: (2022)

Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMA
por: Vos, Wim, et al.
Publicado: (2016)

Hydrocortisone-Loaded Lipid–Polymer Hybrid Nanoparticles for Controlled Topical Delivery: Formulation Design Optimization and In Vitro and In Vivo Appraisal
por: Alsaidan, Omar Awad, et al.
Publicado: (2023)

Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol
por: Calverley, Peter MA, et al.
Publicado: (2012)

Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
por: Bochicchio, Sabrina, et al.
Publicado: (2021)

Roflumilast in COPD: a Brazilian perspective
por: Stirbulov, Roberto, et al.
Publicado: (2015)

Advances in Pulmonary Drug Delivery Systems and Inhalation Formulations
por: Lam, Jenny K. W., et al.
Publicado: (2023)

Influence of cationic lipid concentration on properties of lipid–polymer hybrid nanospheres for gene delivery
por: Bose, Rajendran JC, et al.
Publicado: (2015)

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
por: Kiff, Chris, et al.
Publicado: (2018)

Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang, Linhua, et al.
Publicado: (2015)

Systemic Protein Delivery via Inhalable Liposomes: Formulation and Pharmacokinetics
por: Ponkshe, Pranav, et al.
Publicado: (2023)

Vulnerable COPD patients with comorbidities: the role of roflumilast
por: Lipari, Melissa, et al.
Publicado: (2014)

Efficacy and Safety of Roflumilast in Korean Patients with COPD
por: Lee, Jae Seung, et al.
Publicado: (2016)

Formulation development of lipid polymer hybrid nanoparticles of doxorubicin and its in-vitro, in-vivo and computational evaluation
por: Shafique, Muhammad, et al.
Publicado: (2023)

Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
por: Leong, Ellenmae W. X., et al.
Publicado: (2022)

Single-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery
por: Yi, Yunfeng, et al.
Publicado: (2014)

Hesperidin-Loaded Lipid Polymer Hybrid Nanoparticles for Topical Delivery of Bioactive Drugs
por: Jangde, Rajendra, et al.
Publicado: (2022)

Lipid–Polymer Hybrid Nanosystems: A Rational Fusion for Advanced Therapeutic Delivery
por: Jain, Shweta, et al.
Publicado: (2023)

A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations
por: Barber, Bryce W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2hs9t7665ian4v1a0nectaeu3t